Patricia Simino Boyce
Dennis Tartaglia/Rebecca Janoff
IPRO CEO to be Honored for His Contributions to Health Care Quality in New York
Lake Success, NY, November 28, 2007 – Theodore O. Will, Chief Executive Officer of IPRO, will be honored with the New York Business Group on Health’s (NYBGH) 13th annual Leon J. Warshaw Leadership in Health Care Award. The award recognizes individuals who have shown leadership in New York’s health care community. IPRO is an organization that reports on and works to improve the quality of health care in the state.
The award will be given during NYBGH’s Tribute to Leadership the evening of December 3 at the Union League Club, Manhattan. Also being honored will be Adam Schechter, President, Global Pharmaceuticals, Merck, who will receive the Leadership in Business Award.
“Ted Will and IPRO have been tremendous partners to the New York Business Group on Health and the state’s business community in our efforts to increase health care transparency and promote value-based purchasing,” said Laurel Pickering, Executive Director, New York Business Group on Health. “Their work has made a significant difference in helping New Yorkers choose the best health care options.” NYBGH is a not-for-profit coalition of 150 businesses and is the only organization in the New York metropolitan area exclusively devoted to employer health benefit issues.
IPRO and NYBGH have partnered on a range of projects to inform the business community and consumers about the quality of health care services purchased in New York. The organizations are founding partners in the New York State Health Accountability Foundation, a public-private partnership dedicated to promoting transparency in the health care system and providing employers and consumers with reliable information on health care pricing and quality. The Foundation publishes a yearly regional health care report card.
“I am thrilled to be given this award, and to be among such good company,” said Mr. Will. “It is doubly an honor that the award is coming from the New York Business Group on Health.” Past recipients of the award have been among the most influential health care leaders in the state, such as Herbert Pardes, MD, President and CEO of New York-Presbyterian Hospital. Dr. Pardes received the award in 2006.
Mr. Will has been involved in the management of health care evaluation operations and establishing quality improvement initiatives for more than 25 years. Under Mr. Will’s leadership IPRO has won numerous awards, including ISO 9001:2000 certification and Empire State Advantage Silver recognition.
Providing leadership in a number of national and state health care organizations, Mr. Will is a Fellow of both the American College of Healthcare Executives (ACHE) and the New York Academy of Medicine, and a member of the American Board of Quality Assurance and Utilization Review. He is a member of the Chief Executive Officer’s Section of The American Health Quality Association (AHQA) and has served as Treasurer of the AHQA Board of Directors.
In 1999, Mr. Will was awarded the first annual Healthcare Quality Improvement Distinguished Executive Leadership Award. The award, which is sponsored by the James Q. Cannon Memorial Endowment, was presented at the 1999 AHQA Annual Session. Mr. Will received a Master’s Degree in Public Administration, Health Policy, Planning and Administration from New York University.
With more than 20 years of experience in health care quality improvement and evaluation, IPRO holds major contracts with state and federal governments to review the cost and quality of services provided to Medicaid recipients, Medicare beneficiaries, and patients enrolled in managed care organizations and to work with the health care community to improve those services. IPRO also manages the Medicare-designated End Stage Renal Disease Network of New York. Based in Lake Success, New York, IPRO also holds contracts with private-sector clients to improve the quality of privately financed services.